Cyclacel Pharmaceuticals

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CYCC and other ETFs, options, and stocks.

About CYCC

Cyclacel Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It uses cell cycle, transcriptional regulation and DNA damage response biology to develop medicines for cancer and other proliferative diseases. 

CEO
Spiro Rombotis
CEOSpiro Rombotis
Employees
Employees
Headquarters
Berkeley Heights, New Jersey
HeadquartersBerkeley Heights, New Jersey
Founded
1996
Founded1996
Employees
Employees

CYCC Key Statistics

Market cap
16.80M
Market cap16.80M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
157.06K
Average volume157.06K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$5.85
52 Week high$5.85
52 Week low
$1.01
52 Week low$1.01

CYCC Earnings

-$1.34
-$0.89
-$0.45
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 9, After Hours
ActualExpected Nov 9, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.